Alzheon is committed to developing innovative medicines by directly addressing the underlying pathology of devastating neurodegenerative disorders.

Biotechnology

Alzheon

Alzheon's headquarters in Framingham, MA, United States

Martin Tolar

Adem Albayrak

Stacey Kaufusi

Earvin Liang

Yasemin Khakian

John Hey

Susan Abushakra

Kenneth Mace

Aidan Power

Diane K. Jorkasky

Jordan Heller

Christopher Noel Dunn

Neil Flanzraich

Kaj Blennow

Jakub Hort

Serge Gauthier

Steven Jacobsen

Louis Kirby

Miia Kivipelto

William Mobley

Anton Porsteinsson

John Sampalis

Eric Reiman

Pete Snyder

Bruno Vellas

Keith Crutcher

Cyril Höschl

Marwan N. Sabbagh

Katerina Sheardova

Carmela R. Abraham

Murali Doraiswamy

Ara S. Khachaturian

Michael W. Weiner

Carl Sadowsky

The Scientific Advisory Team at Alzheon consists of a group of leading experts who provide strategic guidance and expertise on the scientific research and development of innovative medicines targeting neurodegenerative disorders. They play a critical role in aligning the company’s efforts with the latest advancements in scientific knowledge and clinical practices.

Scientific Advisory Team

The Leadership Team at Alzheon is responsible for shaping the strategic direction and operational oversight of the company. Comprising key executives including the CEO, CFO, and various vice presidents, this team collaborates to drive clinical development, ensure financial health, and guide the organization's mission to bring innovative treatments for neurodegenerative disorders from concept to reality. Their collective expertise fosters innovation, supports cross-functional collaboration, and navigates regulatory challenges, ultimately aiming to enhance patient outcomes.

Leadership Team

The Marketing and Commercial team at Alzheon is responsible for developing and implementing strategies to effectively market and distribute innovative neurodegenerative disease therapies. This includes brand positioning, market access, managed care negotiations, and overseeing commercial operations to ensure successful product launches and market penetration.

Marketing and Commercial

The Clinical Team at Alzheon is responsible for designing, overseeing, and managing all clinical trials and research studies to ensure the development of effective, safe, and innovative treatments for neurodegenerative disorders. This includes strategic planning, regulatory compliance, and collaboration with medical and operational experts to facilitate successful trial outcomes.

Clinical Team

This department focuses on leveraging data to drive insights, inform decision-making, and develop predictive models.

Data Science

The Finance Team at Alzheon, comprised of the Chief Financial Officer, VP of Finance, and Finance Manager, is responsible for managing the company’s financial health. They oversee budgeting, forecasting, financial planning, and analysis to ensure funding and resources are optimally allocated towards the development of innovative medicines for neurodegenerative disorders.

Finance Team

��

Alzheon

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Marketing and Commercial

Clinical Team

Data Science

Finance Team

Offices

��������

Alzheon

Org chart

Board & advisors

Teams

Scientific Advisory Team

Leadership Team

Marketing and Commercial

Clinical Team

Data Science

Finance Team

Offices

Related companies

��